Design [Regulatives / Guidelines]

posted by Pharma_88 – India, 2020-08-27 16:07 (392 d 18:39 ago) – Posting: # 21893
Views: 2,807

Dear All,

We are thinking to perform steady state BE study for XXX submission where Test product is ER formulation and Reference product is IR formulation. Further, Its HVD product. So, question is whether is this feasible to conduct replicate BE IR vs ER and if yes then what are the parameters for conclusion?

Thanks.

Complete thread:

Activity
 Admin contact
21,693 posts in 4,535 threads, 1,541 registered users;
online 4 (1 registered, 3 guests [including 2 identified bots]).
Forum time: Friday 10:47 CEST (Europe/Vienna)

Tortured data will confess to anything.    Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5